Figures & data
Figure 1 Different cisplatin chemosensitivity in bladder cancer cells.
Abbreviations: DOCK1, dedicator of cytokinesis 1; h, hours.
![Figure 1 Different cisplatin chemosensitivity in bladder cancer cells.](/cms/asset/817102db-ac86-4bb2-af10-37457e6b24ec/dddt_a_12163055_f0001_c.jpg)
Figure 2 Downregulation of DOCK1 sensitized bladder cancer cells to cisplatin.
Abbreviations: DOCK1, dedicator of cytokinesis 1; siRNA, small interfering RNA.
![Figure 2 Downregulation of DOCK1 sensitized bladder cancer cells to cisplatin.](/cms/asset/a7ec17c5-344a-42c7-b697-4da37b0b70f0/dddt_a_12163055_f0002_c.jpg)
Figure 3 Cisplatin treatment induced EMT in bladder cancer cells.
Abbreviations: EMT, epithelial–mesenchymal transition; siRNA, small interfering RNA.
![Figure 3 Cisplatin treatment induced EMT in bladder cancer cells.](/cms/asset/92a9981d-16aa-4c7d-b219-081bd921c74b/dddt_a_12163055_f0003_c.jpg)
Figure 4 DOCK1 regulated EMT in bladder cancer cells.
Abbreviations: DOCK1, dedicator of cytokinesis 1; EMT, epithelial–mesenchymal transition; siRNA, small interfering RNA.
![Figure 4 DOCK1 regulated EMT in bladder cancer cells.](/cms/asset/b8639fef-0408-42bd-b00a-c425abaf1050/dddt_a_12163055_f0004_b.jpg)
Figure 5 Cisplatin-induced EMT was dependent on DOCK1.
Abbreviations: EMT, epithelial–mesenchymal transition; DOCK1, dedicator of cytokinesis 1; siRNA, small interfering RNA.
![Figure 5 Cisplatin-induced EMT was dependent on DOCK1.](/cms/asset/00f18310-80d5-4e43-b5e3-a731076cae2c/dddt_a_12163055_f0005_b.jpg)
Figure 6 DOCK1 knockdown sensitized bladder cancer cells to cisplatin via EMT.
Abbreviations: DOCK1, dedicator of cytokinesis 1; EMT, epithelial–mesenchymal transition; siRNA, small interfering RNA.
![Figure 6 DOCK1 knockdown sensitized bladder cancer cells to cisplatin via EMT.](/cms/asset/89d17c3f-d29a-40f6-a70f-623f409b2f53/dddt_a_12163055_f0006_b.jpg)